SEC 13F Intelligence

Spring Creek Capital LLC / ALXN

Spring Creek Capital LLC’s Alexion Pharmaceuticals Inc Position

Does Spring Creek Capital LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 372.0K shares worth $68M in Q2 2021; the fund’s latest 13F (Q3 2023) no longer reports it.

Position Value
$68M
Q2 2021
Shares
372.0K
% of Portfolio
+3.39%
Quarters Held
3
position exited

Position History ALXN

Reported value by quarter
Q4 ’20: $27MQ4 ’20Q1 ’21: $86MQ1 ’21Q2 ’21: $68MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021372.0K$68M+3.39%
Q1 2021562.9K$86M+3.72%
Q4 2020176.0K$27M+2.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Spring Creek Capital LLC’s full portfolio or all institutional holders of ALXN.